Company profile
HpVac company profile
GBC-HpVac focuses on the development of GBC-R1 as a preventive and therapeutic first-line therapy for asthma and related allergic diseases. GBC-HpVac holds an exclusive, worldwide license from the University of Zurich. GBC-HpVac was founded in 2016 and is headquartered in Geneva, Switzerland.
Business identity
- Website
- https://www.gbc-hpvac.com
- Contact email
- [email protected]
- Phone number
- +41 22 794 40 20
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2016-06-01
Headquarters
- Headquarters
- Hasle, Lucerne, Switzerland
- Postal code
- Switzerland
- Country code
- CH
- Continent
- Europe